Back to Authors

Patel, Samir H.

https://orcid.org/0000-0002-8251-574X

Mayo Clinic

Mayo Clinic

Citations 44

ACR Appropriateness Criteria ® Pre-Irradiation Evaluation and Management of Brain Metastases
Lo, Simon S. , Gore, Elizabeth , Bradley, Jeffrey D. , Buatti, John M. , Germano, Isabelle M. , Ghafoori, A. Paiman, Henderson, M. , Murad, Gregory J. A. , Patchell, Roy A., Patel, Samir H. , Robbins, Jared R. , Robins, H. Ian, Vassil, Andrew D. , Wippold, Franz J. , Yunes, Michael J. , Videtic, Gregory M.M. , Bradley, Jeffrey , Buatti, John M

Journal of Palliative Medicine | June 27, 2014 | Volume: 17 | Issue: 8 | Pages: 880-886

10.1089/jpm.2014.9417 Get It

Abstract Pretreatment evaluation is performed to determine the number, location, and size of the brain metastases and magnetic resonance imaging (MRI) is the recommended imaging technique, particularly in patients being considered for surgery or stereotactic radiosurgery. A contiguous thin-cut volumetric MRI with gadolinium with newer gadolinium-based agents can improve detection of small brain metastases. A systemic workup and medical evaluation are important, given that subsequent treatment for the brain metastases will also depend on the extent of the extracranial disease and on the age and performance status of the patient. Patients with hydrocephalus or impending brain herniation should be started on high doses of corticosteroids and evaluated for possible neurosurgical intervention. Patients with moderate symptoms should receive approximately 4–8 mg/d of dexamethasone in divided doses. The routine use of corticosteroids in patients without neurologic symptoms is not necessary. There is no proven benefit of anticonvulsants in patient without seizures. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Reply to Letter to the Editor regarding transoral laser microsurgery
Patel, Samir H. , Hinni, Michael L., Hayden, Richard E. , Halyard, Michele Y.

Head & Neck | June 21, 2014 | Volume: 36 | Issue: 11 | Pages: 1675-1675

10.1002/hed.23810 Get It

Relapse Patterns After Transoral Laser Microsurgery and Postoperative Irradiation for Squamous Cell Carcinomas of the Tonsil and Tongue Base
Patel, Samir H. , Munson, Nathan D. , Grant, David G., Buskirk, Steven J., Hinni, Michael L., Perry, William C., Foote, Robert L. , McNeil, Rebecca B. , Halyard, Michele Y.

Annals of Otology, Rhinology & Laryngology | February 27, 2014 | Volume: 123 | Issue: 1 | Pages: 32-39

10.1177/0003489414521383 Get It

Objectives: We evaluated relapse patterns after transoral laser microsurgery (TLM) in squamous cell carcinoma (SCC) of the tonsil and tongue base and evaluated the indications for adjuvant irradiation. Methods: Between December 1, 1996, and December 31, 2005, 79 patients with previously untreated SCC of the tonsil or tongue base underwent TLM with or without neck dissection. Thirty-eight patients (48%) underwent postoperative irradiation (median, 62 Gy) to the primary site and the neck. Analysis of relapse patterns was performed on the basis of adverse risk factors and the presence or absence of adjuvant irradiation. Results: The median follow-up for living patients was 47 months (range, 10 to 107 months), and patients were monitored for at least 2 years or until recurrence or death. Local, regional, and distant treatment failures numbered 4, 6, and 4 for surgery alone (n = 41) and 0, 2, and 6 for adjuvant irradiation (n = 38), respectively. Patients with high-risk features (extracapsular extension or at least 2 adverse factors) had locoregional control rates at 2 or more years of 66% and 94% for TLM alone and TLM plus adjuvant irradiation, respectively. Conclusions: Adjuvant irradiation after TLM resection of oropharyngeal SCC with intermediate- or high-risk features improves locoregional control compared with TLM alone.
Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: The mayo clinic arizona experience
Patel, Samir H. , Hinni, Michael L., Hayden, Richard E. , Wong, William W. , Dueck, Amylou C. , Zarka, Matthew A., Curtis, Kelly K., Halyard, Michele Y. , Dueck, A. C.

Head & Neck | March 26, 2013 | Volume: 36 | Issue: 2 | Pages: 220-225

10.1002/hed.23279 Get It

BackgroundThe purpose of this study was to report the treatment outcomes of patients with advanced oropharyngeal cancer treated with transoral laser microsurgery (TLM) followed by radiation therapy (RT) at Mayo Clinic in Arizona.MethodsA retrospective study of 80 patients treated from January 1, 2000 to November 7, 2011 was performed. All patients had stage III/IV oropharyngeal tumors and underwent TLM with neck dissection. Adjuvant RT was then given. Thirty‐seven patients received concurrent adjuvant chemotherapy. The primary outcome was locoregional control.ResultsMedian follow‐up was 47.3 months (range, 9.7–139.2 months). The 3‐year locoregional control, recurrence‐free survival, and overall survival rates were 98.6% (95% confidence interval [CI], 91% to 100%), 91.1% (95% CI, 81% to 96%), and 93.7% (95% CI, 84% to 98%), respectively. There were a total of 5 treatment failures, 1 regional and 4 distant. Twenty‐six patients underwent neck only RT with exclusion of the primary site.ConclusionTLM followed by RT for advanced oropharyngeal cancer results in excellent locoregional control rates. © 2013 Wiley Periodicals, Inc. Head Neck 36: 220–225, 2014